Zuprevo™ (tildipirosin) 18% is indicated for the treatment of bovine
respiratory disease (BRD) associated with Mannheimia haemolytica,
Pasteurella multocida, and Histophilus somni in beef and non-lactating
dairy cattle, and for the control of respiratory disease in beef and
non-lactating dairy cattle at high risk of developing BRD associated
with Mannheimia haemolytica, Pasteruella multocida, and Histophilus
somni. Contains 180 mg tildipirosin, a semi-synthetic macrolide
antibiotic. Ready-to-use solution. Subcutaneous injection.
respiratory disease (BRD) associated with Mannheimia haemolytica,
Pasteurella multocida, and Histophilus somni in beef and non-lactating
dairy cattle, and for the control of respiratory disease in beef and
non-lactating dairy cattle at high risk of developing BRD associated
with Mannheimia haemolytica, Pasteruella multocida, and Histophilus
somni. Contains 180 mg tildipirosin, a semi-synthetic macrolide
antibiotic. Ready-to-use solution. Subcutaneous injection.
- (Loading SDS PDF) SDS Sheet